Balchem CORP Form 4 insider transactions

Matthew Wineinger, a director at Balchem Corp, filed an amended Form 4 to correct the vesting period of restricted stock from three years to one year.

Monica Vicente, a director at Balchem Corp, filed an amended SEC Form 4/A to correct the vesting period of restricted stock from three years to one year.

Job Leonard van Gunsteren, SVP and GM of Specialty Products at Balchem Corp, reports acquisition and disposal of common stock and stock options.

Michael Brent Tignor, SVP & Chief HR Officer of Balchem Corp, reports acquisition and disposal of common stock and stock options.

SVP Chief Supply Chain Officer Reid Martin Luther files an amended Form 4/A detailing stock transactions and vesting schedules for Balchem Corporation.

William A. Backus, VP & Chief Accounting Officer of Balchem Corp, reports acquisition and disposal of common stock and stock options, along with an amendment to a previous filing regarding restricted stock vesting.

Hatsuki Miyata, EVP, CLO, & Secretary of Balchem Corp, reports acquisition of common stock and stock options, along with adjustments to previously reported vesting details.

EVP & Chief Financial Officer of Balchem Corp, Carl Martin Bengtsson, reports acquisition and disposal of common stock and stock options.

Theodore L. Harris, Chairman, President & CEO of Balchem Corp, reports acquisition and disposal of common stock and stock options, along with an amendment to the vesting schedule of restricted stock.

Frederic Boned, SVP/GM of Human Nutrition & Health at Balchem Corp, acquired common stock and stock options, and an amendment was filed to correct the vesting period of restricted stock.

Kathleen B Fish, a director at Balchem Corp, amended a previous Form 4 filing to correct the vesting period of restricted stock from three years to one year.

Daniel E. Knutson, a director at Balchem Corp, filed an amended SEC Form 4/A to correct the vesting period of restricted stock from three years to one year.

SVP and GM of Specialty Products at Balchem Corp, Job Leonard van Gunsteren, reports acquisition and disposal of common stock and stock options.

Martin Luther Reid, SVP Chief Supply Chain Officer at Balchem Corp, reports acquisition and disposal of common stock and stock options.

Michael Brent Tignor, SVP & Chief HR Officer at Balchem Corp, reports acquisition and disposal of common stock and stock options.

Theodore L Harris, Chairman, President & CEO of Balchem Corp, reports acquisition and disposal of common stock and stock options.

EVP, General Counsel & Secretary of Balchem Corp, Hatsuki Miyata, reports acquisition of common stock and stock options.

Michael Robert Sestrick, SVP & Chief Technology Officer of Balchem Corp, reports the vesting of performance stock units and subsequent tax withholding.

Carl Martin Bengtsson, EVP & Chief Financial Officer of Balchem Corp, reports acquisition and disposal of common stock and stock options.

Frederic Boned, SVP/GM of Human Nutrition & Health at Balchem Corp, reports acquisition of common stock and stock options.

William A. Backus, VP & Chief Accounting Officer of Balchem Corp, reports acquisition and disposal of common stock and stock options.

Director Monica Vicente reports acquisition and disposal of Balchem Corp (BCPC) common stock on February 12, 2025.

Director Matthew David Wineinger reported acquiring 980 shares of Balchem Corp common stock on February 12, 2025.

Director David B Fischer reports acquiring 980 shares of Balchem Corp common stock on February 12, 2025.

Director Kathleen B. Fish reported acquiring 980 shares of Balchem Corp common stock on February 12, 2025.

Director Olivier Rigaud reports changes in beneficial ownership of Balchem Corp stock, including acquisition of 980 shares and disposal of 1,520 shares on February 12, 2025.

Director Daniel E. Knutson reported acquiring 980 shares of Balchem Corp common stock on February 12, 2025.

William A. Backus, VP & Chief Accounting Officer of Balchem Corp, sold 310 shares of common stock on February 10, 2025, to cover withholding taxes due upon the vesting of restricted shares.

Carl Martin Bengtsson, EVP & Chief Financial Officer of Balchem Corp, sold shares to cover withholding taxes upon the vesting of restricted shares.

Chairman, President, and CEO of Balchem Corp, Theodore L. Harris, disposed of shares to cover withholding taxes upon vesting of restricted shares.